# Gilwan Kim

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gilwan-kim/

## Facts

| Field | Value |
| --- | --- |
| Citations | 650 |
| Field | Migraine and Headache Studies |
| h-index | 13 |
| i10-index | 15 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5027620562 |
| ORCID iD | 0000-0003-1991-6644 |
| Works | 40 |

## Researcher papers

- [Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria](https://scholariq.org/papers/prevalence-of-comorbid-conditions-among-adult-patients-diagnosed-with/)
- [Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data](https://scholariq.org/papers/higher-incidence-rates-of-comorbidities-in-patients-with-psoriatic-arthritis/)
- [Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set](https://scholariq.org/papers/evaluation-of-the-comorbidity-burden-in-patients-with-ankylosing-spondylitis/)
- [Clinical and Economic Burden of Antineutrophil Cytoplasmic Antibody–associated Vasculitis in the United States](https://scholariq.org/papers/clinical-and-economic-burden-of-antineutrophil-cytoplasmic-antibody-associated/)
- [Factors Associated with Direct Health Care Costs Among Patients with Migraine](https://scholariq.org/papers/factors-associated-with-direct-health-care-costs-among-patients-with-migraine/)
- [Healthcare Utilization and Direct Costs in Patients with Ankylosing Spondylitis Using a Large US Administrative Claims Database](https://scholariq.org/papers/healthcare-utilization-and-direct-costs-in-patients-with-ankylosing-spondylitis/)
- [Improving adherence to acne treatment: the emerging role of application software](https://scholariq.org/papers/improving-adherence-to-acne-treatment-the-emerging-role-of-application-software/)
- [Factors Associated with the Initiation of Biologic Disease-Modifying Antirheumatic Drugs in Texas Medicaid Patients with Rheumatoid Arthritis](https://scholariq.org/papers/factors-associated-with-the-initiation-of-biologic-disease-modifying/)
- [Societal burden of cluster headache in the United States: a descriptive economic analysis](https://scholariq.org/papers/societal-burden-of-cluster-headache-in-the-united-states-a-descriptive-economic/)
- [Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis](https://scholariq.org/papers/examining-time-to-initiation-of-biologic-disease-modifying-antirheumatic-drugs/)
- [Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United States](https://scholariq.org/papers/health-care-resource-utilization-and-direct-costs-incurred-over-24-months-after/)

## Researcher topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Traumatic Brain Injury Research](https://scholariq.org/topics/traumatic-brain-injury-research/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.